Show
10
20
30
40
results per page
COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein
Perrin, David M |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
Discovery of small molecules targeting SARS-CoV-2 frameshifting using a rapid yeast platform
Jan, Eric |
University of British Columbia | Project Grant | $445,230
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics
Haas, Kurt |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Protecting healthcare workers from COVID-19: A comparative contextualized analysis
Yassi, Annalee |
University of British Columbia | Operating Grant | $49,626
CIHR British Columbia 2021
Read More
All-cause and cause-specific acute morbidity attributable to Covid-19 epidemic, severe Covid-19 symptoms, and adverse birth outcomes in Canada.
Lisonkova, Sarka |
University of British Columbia | Project Grant | $168,300
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Canadian Treatments for COVID-19: SOLIDARITY
Murthy, Srinivas |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
COVID-19 Variant Supplement – Assessing the impact of the COVID‑19 pandemic on social and health outcomes among young people: A mixed-method comparative analysis in Canada and France
Knight, Rodney E |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases
Strynadka, Natalie C |
University of British Columbia | Operating Grant | $100,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Host cellular protein substrates of SARS-CoV-2 proteases
Jan, Eric |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases
Strynadka, Natalie C |
University of British Columbia | Operating Grant | $50,000
CIHR British Columbia 2021
Read More